Limited evidence of patient-to-patient transmission of Staphylococcus aureus strains between children with cystic fibrosis, Queensland, Australia.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2022
2022
Historique:
received:
13
02
2022
accepted:
13
09
2022
entrez:
7
10
2022
pubmed:
8
10
2022
medline:
12
10
2022
Statut:
epublish
Résumé
Here we used whole genome sequencing (WGS) to understand strain diversity and potential for patient-to-patient transmission of Staphylococcus aureus among children with cystic fibrosis (CF) in Queensland, Australia. S. aureus isolates (n = 401) collected between January 2018 and April 2019 from 184 patients with CF (n = 318 isolates) and 76 patients without CF (n = 83 isolates) were subjected to WGS and subsequent multilocus sequence typing (MLST), and a phylogeny was constructed from core genome single nucleotide polymorphism (SNP) analysis. The subsequent data was compared with available patient information. WGS revealed that patients with CF were essentially colonised by the same genotypes as those seen in patients without CF. Sequence types (ST) for our patients with CF were predominantly ST5 (20.1%), ST30 (7.3%), ST15 (6.3%) and ST8 (5.3%). Two Australian clones, ST93 and ST239, typically seen in skin infections and health-care settings, respectively, were notably absent from our patients with CF. Based on a SNP distance threshold of 14 SNPs, 20 cluster types involving 50/260 patients were evident; of these, 6 clusters contained only patients found to be siblings or otherwise living in the same household. Epidemiological relationships could not be determined for a remaining 14 cluster types involving 38 patients, comprising 2-7 (median 2) patients each. Multiple S. aureus genotypes were observed in 19/73 CF patients who provided more than one sample. These results show that WGS is a useful tool for surveillance of S. aureus strains in children with CF and that the strains in our CF cohort were largely consistent with those circulating in patients without CF. Overall, this confirms previous findings and indicates that S. aureus acquisition in children with CF is similar to that of other patient groups, with limited evidence of potential patient-to-patient transmission within this patient group.
Identifiants
pubmed: 36206247
doi: 10.1371/journal.pone.0275256
pii: PONE-D-22-04232
pmc: PMC9543978
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0275256Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Antimicrob Agents Chemother. 2009 Dec;53(12):4961-7
pubmed: 19721075
Microb Genom. 2016 Apr 29;2(4):e000056
pubmed: 28348851
Infect Drug Resist. 2018 Feb 22;11:247-255
pubmed: 29503574
J Clin Microbiol. 2014 May;52(5):1529-39
pubmed: 24574292
Antibiotics (Basel). 2022 Jan 11;11(1):
pubmed: 35052963
Hereditas. 2016 Nov 14;153:11
pubmed: 28096773
Infect Control Hosp Epidemiol. 2006 Feb;27(2):201-3
pubmed: 16465641
mSphere. 2018 Feb 14;3(1):
pubmed: 29468193
J Clin Microbiol. 2009 Jan;47(1):73-8
pubmed: 18971362
Eur Respir J. 2013 May;41(5):1091-100
pubmed: 22878877
J Clin Microbiol. 2014 Jan;52(1):139-46
pubmed: 24172157
Eur J Clin Microbiol Infect Dis. 2010 Oct;29(10):1277-85
pubmed: 20602245
Trends Microbiol. 2015 Jul;23(7):437-44
pubmed: 25864883
Chest. 2007 Jun;131(6):1718-25
pubmed: 17400676
BMC Bioinformatics. 2010 Dec 10;11:595
pubmed: 21143983
Lancet Infect Dis. 2018 Nov;18(11):1269-1277
pubmed: 30274723
Lancet. 1968 Feb 10;1(7537):270-2
pubmed: 4170754
JAMA. 2010 Jun 16;303(23):2386-92
pubmed: 20551409
Genome Res. 2013 Apr;23(4):653-64
pubmed: 23299977
Vet Microbiol. 2006 Jun 15;115(1-3):148-55
pubmed: 16464540
Ann Am Thorac Soc. 2015 Jun;12(6):864-71
pubmed: 25745825
PLoS One. 2012;7(8):e43037
pubmed: 22900085
Nucleic Acids Res. 2020 Jan 8;48(D1):D517-D525
pubmed: 31665441
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
Nat Biotechnol. 2013 Apr;31(4):294-6
pubmed: 23563421
Breathe (Sheff). 2018 Jun;14(2):87-90
pubmed: 29877519
Commun Dis Intell (2018). 2020 Sep 15;44:
pubmed: 32988337
J Hosp Infect. 2006 Feb;62(2):187-94
pubmed: 16290319
Diagn Microbiol Infect Dis. 2014 Jan;78(1):59-62
pubmed: 24211217
J Antimicrob Chemother. 2012 Nov;67(11):2640-4
pubmed: 22782487
J Cyst Fibros. 2011 Dec;10(6):407-11
pubmed: 21752729
Microb Genom. 2021 Mar;7(3):
pubmed: 33599606
Lancet Infect Dis. 2013 Feb;13(2):130-6
pubmed: 23158674
Lab Invest. 2007 Jan;87(1):3-9
pubmed: 17146447
Front Genet. 2019 Jun 12;10:546
pubmed: 31244886
Clin Microbiol Rev. 2002 Apr;15(2):194-222
pubmed: 11932230
Emerg Infect Dis. 2019 Jan;25(1):190-192
pubmed: 30561308
Int J Infect Dis. 2003 Dec;7(4):259-64
pubmed: 14656416
Nucleic Acids Res. 2019 Jul 2;47(W1):W256-W259
pubmed: 30931475
Eur Respir J. 2012 Jul;40(1):227-38
pubmed: 22323572
Sci Transl Med. 2017 Oct 25;9(413):
pubmed: 29070701
Biol Direct. 2009 Jan 13;4:1
pubmed: 19144117
BMC Infect Dis. 2016 Aug 08;16:382
pubmed: 27502499
Eur Respir J. 2004 Jul;24(1):101-6
pubmed: 15293611
Lancet. 2002 Mar 2;359(9308):753-9
pubmed: 11888586
Chest. 2008 Jun;133(6):1381-1387
pubmed: 18347206
Am J Respir Crit Care Med. 2008 Oct 15;178(8):814-21
pubmed: 18669817
Microbiome. 2020 Apr 2;8(1):45
pubmed: 32238195
J Comput Biol. 2012 May;19(5):455-77
pubmed: 22506599
Drug Resist Updat. 2015 Jul-Aug;21-22:41-59
pubmed: 26304792
Mol Biol Evol. 2018 Feb 1;35(2):518-522
pubmed: 29077904
Mol Biol Evol. 2015 Jan;32(1):268-74
pubmed: 25371430
Genome Res. 2016 Feb;26(2):263-70
pubmed: 26672018
Emerg Infect Dis. 2005 May;11(5):711-4
pubmed: 15890125
Genome Med. 2018 Nov 13;10(1):82
pubmed: 30424799
PLoS One. 2011;6(10):e25887
pubmed: 21991381
Nucleic Acids Res. 2016 Jan 4;44(D1):D694-7
pubmed: 26578559
mBio. 2020 Jun 23;11(3):
pubmed: 32576671
J Clin Microbiol. 2003 Nov;41(11):5199-201
pubmed: 14605162
Antimicrob Agents Chemother. 2019 Oct 22;63(11):
pubmed: 31427293
Med J Aust. 2001 Jun 18;174(12):662
pubmed: 11480692
mBio. 2012 Feb 28;3(2):
pubmed: 22375071
Int J Med Microbiol. 2013 Dec;303(8):685-92
pubmed: 24183484
Nat Methods. 2017 Jun;14(6):587-589
pubmed: 28481363
Infect Genet Evol. 2014 Jan;21:515-22
pubmed: 23722021
J Hosp Infect. 2019 Jun;102(2):189-199
pubmed: 30721732
BMC Bioinformatics. 2018 Aug 29;19(1):307
pubmed: 30157759
Thorax. 2009 Jun;64(6):535-40
pubmed: 19282318
PLoS One. 2011 Apr 06;6(4):e17936
pubmed: 21494333
Appl Environ Microbiol. 2014 Dec;80(23):7275-82
pubmed: 25239891
Respiration. 2015;89(5):390-5
pubmed: 25825042
Lancet. 1993 Apr 24;341(8852):1065-9
pubmed: 7682274
Wellcome Open Res. 2018 Sep 24;3:124
pubmed: 30345391
Clin Infect Dis. 2021 Nov 2;73(9):e2521-e2528
pubmed: 32544950
Environ Sci Pollut Res Int. 2019 Dec;26(34):34741-34753
pubmed: 31654301
Lancet Respir Med. 2015 Aug;3(8):640-50
pubmed: 26208994
Antimicrob Agents Chemother. 2007 Jan;51(1):264-74
pubmed: 17043114
BMC Bioinformatics. 2009 Dec 15;10:421
pubmed: 20003500
J Clin Microbiol. 2017 Jul;55(7):2143-2152
pubmed: 28446577
Mol Biol Evol. 2009 Jul;26(7):1641-50
pubmed: 19377059
Proc Natl Acad Sci U S A. 2014 May 6;111(18):6738-43
pubmed: 24753569
Nucleic Acids Res. 2015 Feb 18;43(3):e15
pubmed: 25414349
J Clin Microbiol. 2003 Sep;41(9):4424-7
pubmed: 12958283